Akero Therapeutics (AKRO) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

AKRO is expected to report earnings to rise 10.48% to -115 cents per share on March 13

Akero Therapeutics AKRO Stock Earnings Reports

Q4'24

Est.

$-1.16

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.02

Q1'24

Est.

$-0.90

Q4'23

Missed

by $0.16

The last earnings report on November 08 showed earnings per share of -104 cents, missing the estimate of -87 cents. With 768.51K shares outstanding, the current market capitalization sits at 2.14B.

View a ticker or compare two or three

Compare

AKRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKRO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AKRO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

601 Gateway Boulevard

Phone

+1 650 487-6488

Employees

Web

https://www.akerotx.com